Advertisement

Thrombolytic Therapy: State of the Art

  • M. L. Simoons
Conference paper

Abstract

It is dangerous to take a position on the “state of the art” of thrombolytic therapy, particularly since a number of larger studies are being conducted and may be completed before this paper appears. The available data at the time of this meeting have convinced us that thrombolytic therapy is the preferred mode of treatment in a subgroup of patients with acute myocardial infarction: patients with extensive anterior myocardial ischemia or inferoposterior ischemia, who can be treated within 4–6 h after the onset of symptoms.

Keywords

Acute Myocardial Infarction Infarct Size Thrombolytic Therapy Global Left Ventricular Function Regional Left Ventricular Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1: 397–402Google Scholar
  2. 2.
    Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto miocardico (GISSI) (1987) Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 2: 871–874Google Scholar
  3. 3.
    Kennedy JW, Ritchie JL, Davis KB, Fritz JK (1985) Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: a 12-month follow-up report. N Engl J Med 312: 1073–1078PubMedCrossRefGoogle Scholar
  4. 4.
    Simoons ML, Serruys PW, van den Brand M et al. (1985) Improved survival after early thrombolysis in acute myocardial infarction: a randomized trial by the Interuniversity Cardiology Institute in the Netherlands. Lancet 2: 578–582PubMedCrossRefGoogle Scholar
  5. 5.
    Simoons ML, Serruys PW, van den Brand M et al. (1986) Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol 7: 717–728PubMedCrossRefGoogle Scholar
  6. 6.
    Serruys PW, Simoons ML, Suryapranata H et al. (1986) Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 729–742Google Scholar
  7. 7.
    Vermeer F, Simoons ML, Bär FW et al. (1986) Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation 74: 1379–1389PubMedCrossRefGoogle Scholar
  8. 8.
    Vermeer F, Simoons ML, Zwaan C de etal. Cost benefit analysis of early thrombolytic therapy with intracoronary streptokinase. Br Heart J (in press)Google Scholar
  9. 9.
    Erbel R, Pop T, Henrichs KJ et al. (1986) Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. J Am Coll Cardiol 8: 485–495PubMedCrossRefGoogle Scholar
  10. 10.
    Topol EJ, Califf RM, George BS etal., TAMI Study Group (1987) A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 317: 581–588Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • M. L. Simoons

There are no affiliations available

Personalised recommendations